Cargando…

Efficacy and safety of Parecoxib for prevention of catheter-related bladder discomfort in patients undergoing transurethral resection of bladder tumor: Prospective randomised trial

BACKGROUND AND AIMS: Catheter-related bladder discomfort (CRBD) is the urge to void or discomfort in the suprapubic region secondary to an indwelling urinary catheter. We aimed to evaluate the safety and efficacy of single-dose of intravenous parecoxib in reducing the incidence and severity of CRBD...

Descripción completa

Detalles Bibliográficos
Autores principales: Jendoubi, Ali, Aissi, Wafa, Abbes, Ahmed, Bouzouita, Abderrazek, Fourati, Sami, Necib, Hatem, Ghedira, Salma, Houissa, Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6004747/
https://www.ncbi.nlm.nih.gov/pubmed/29962529
http://dx.doi.org/10.4103/ija.IJA_137_18
_version_ 1783332574530109440
author Jendoubi, Ali
Aissi, Wafa
Abbes, Ahmed
Bouzouita, Abderrazek
Fourati, Sami
Necib, Hatem
Ghedira, Salma
Houissa, Mohamed
author_facet Jendoubi, Ali
Aissi, Wafa
Abbes, Ahmed
Bouzouita, Abderrazek
Fourati, Sami
Necib, Hatem
Ghedira, Salma
Houissa, Mohamed
author_sort Jendoubi, Ali
collection PubMed
description BACKGROUND AND AIMS: Catheter-related bladder discomfort (CRBD) is the urge to void or discomfort in the suprapubic region secondary to an indwelling urinary catheter. We aimed to evaluate the safety and efficacy of single-dose of intravenous parecoxib in reducing the incidence and severity of CRBD in patients undergoing transurethral resection of bladder tumor (TURBT). METHODS: Sixty-one adult patients, American Society of Anesthesiologists physical status I or II, undergoing elective TURBT under spinal anaesthesia, were randomly allocated to receive 40 mg of IV parecoxib (group P; n = 29) or an equal volume of normal saline (control group C; n = 32). CRBD was graded as none, mild, moderate, and severe. Between-group comparisons were made for the incidence and severity of CRBD, postoperative Visual analog scales (VAS), rescue analgesia equirements, and occurrence of adverse events. Statistical analysis done with the Mann–Whitney U-test and Fisher's Exact Test. A P value of ≤ 0.05 was considered statistically significant. RESULTS: Parecoxib significantly reduced the incidence and severity of CRBD at 2, 4, 6, and 12 hours postoperatively compared to placebo (P < 0.05). Median pain VAS scores were lower in the P group at all times except the first hour. Rescue analgesia was given to more patients in group C (16/32, 50%) than in group P (1/29) (P < 0.001). None of the patients who received parecoxib experienced an adverse event. CONCLUSION: A single intravenous injection of parecoxib is safe and effective in decreasing the incidence and severity of CRBD in patients undergoing TURBT. TRIAL REGISTRATION IDENTIFIER: NCT02729935(www.clinicaltrials.gov).
format Online
Article
Text
id pubmed-6004747
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-60047472018-06-29 Efficacy and safety of Parecoxib for prevention of catheter-related bladder discomfort in patients undergoing transurethral resection of bladder tumor: Prospective randomised trial Jendoubi, Ali Aissi, Wafa Abbes, Ahmed Bouzouita, Abderrazek Fourati, Sami Necib, Hatem Ghedira, Salma Houissa, Mohamed Indian J Anaesth Original Article BACKGROUND AND AIMS: Catheter-related bladder discomfort (CRBD) is the urge to void or discomfort in the suprapubic region secondary to an indwelling urinary catheter. We aimed to evaluate the safety and efficacy of single-dose of intravenous parecoxib in reducing the incidence and severity of CRBD in patients undergoing transurethral resection of bladder tumor (TURBT). METHODS: Sixty-one adult patients, American Society of Anesthesiologists physical status I or II, undergoing elective TURBT under spinal anaesthesia, were randomly allocated to receive 40 mg of IV parecoxib (group P; n = 29) or an equal volume of normal saline (control group C; n = 32). CRBD was graded as none, mild, moderate, and severe. Between-group comparisons were made for the incidence and severity of CRBD, postoperative Visual analog scales (VAS), rescue analgesia equirements, and occurrence of adverse events. Statistical analysis done with the Mann–Whitney U-test and Fisher's Exact Test. A P value of ≤ 0.05 was considered statistically significant. RESULTS: Parecoxib significantly reduced the incidence and severity of CRBD at 2, 4, 6, and 12 hours postoperatively compared to placebo (P < 0.05). Median pain VAS scores were lower in the P group at all times except the first hour. Rescue analgesia was given to more patients in group C (16/32, 50%) than in group P (1/29) (P < 0.001). None of the patients who received parecoxib experienced an adverse event. CONCLUSION: A single intravenous injection of parecoxib is safe and effective in decreasing the incidence and severity of CRBD in patients undergoing TURBT. TRIAL REGISTRATION IDENTIFIER: NCT02729935(www.clinicaltrials.gov). Medknow Publications & Media Pvt Ltd 2018-06 /pmc/articles/PMC6004747/ /pubmed/29962529 http://dx.doi.org/10.4103/ija.IJA_137_18 Text en Copyright: © 2018 Indian Journal of Anaesthesia http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Jendoubi, Ali
Aissi, Wafa
Abbes, Ahmed
Bouzouita, Abderrazek
Fourati, Sami
Necib, Hatem
Ghedira, Salma
Houissa, Mohamed
Efficacy and safety of Parecoxib for prevention of catheter-related bladder discomfort in patients undergoing transurethral resection of bladder tumor: Prospective randomised trial
title Efficacy and safety of Parecoxib for prevention of catheter-related bladder discomfort in patients undergoing transurethral resection of bladder tumor: Prospective randomised trial
title_full Efficacy and safety of Parecoxib for prevention of catheter-related bladder discomfort in patients undergoing transurethral resection of bladder tumor: Prospective randomised trial
title_fullStr Efficacy and safety of Parecoxib for prevention of catheter-related bladder discomfort in patients undergoing transurethral resection of bladder tumor: Prospective randomised trial
title_full_unstemmed Efficacy and safety of Parecoxib for prevention of catheter-related bladder discomfort in patients undergoing transurethral resection of bladder tumor: Prospective randomised trial
title_short Efficacy and safety of Parecoxib for prevention of catheter-related bladder discomfort in patients undergoing transurethral resection of bladder tumor: Prospective randomised trial
title_sort efficacy and safety of parecoxib for prevention of catheter-related bladder discomfort in patients undergoing transurethral resection of bladder tumor: prospective randomised trial
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6004747/
https://www.ncbi.nlm.nih.gov/pubmed/29962529
http://dx.doi.org/10.4103/ija.IJA_137_18
work_keys_str_mv AT jendoubiali efficacyandsafetyofparecoxibforpreventionofcatheterrelatedbladderdiscomfortinpatientsundergoingtransurethralresectionofbladdertumorprospectiverandomisedtrial
AT aissiwafa efficacyandsafetyofparecoxibforpreventionofcatheterrelatedbladderdiscomfortinpatientsundergoingtransurethralresectionofbladdertumorprospectiverandomisedtrial
AT abbesahmed efficacyandsafetyofparecoxibforpreventionofcatheterrelatedbladderdiscomfortinpatientsundergoingtransurethralresectionofbladdertumorprospectiverandomisedtrial
AT bouzouitaabderrazek efficacyandsafetyofparecoxibforpreventionofcatheterrelatedbladderdiscomfortinpatientsundergoingtransurethralresectionofbladdertumorprospectiverandomisedtrial
AT fouratisami efficacyandsafetyofparecoxibforpreventionofcatheterrelatedbladderdiscomfortinpatientsundergoingtransurethralresectionofbladdertumorprospectiverandomisedtrial
AT necibhatem efficacyandsafetyofparecoxibforpreventionofcatheterrelatedbladderdiscomfortinpatientsundergoingtransurethralresectionofbladdertumorprospectiverandomisedtrial
AT ghedirasalma efficacyandsafetyofparecoxibforpreventionofcatheterrelatedbladderdiscomfortinpatientsundergoingtransurethralresectionofbladdertumorprospectiverandomisedtrial
AT houissamohamed efficacyandsafetyofparecoxibforpreventionofcatheterrelatedbladderdiscomfortinpatientsundergoingtransurethralresectionofbladdertumorprospectiverandomisedtrial